Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis
Endoscopy International Open · 12.05.2025 · 13 (CP)
DOI: 10.1055/a-2586-6007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endoscopy International Open, online erschienen am 12.05.2025. Verfasst von Marco Valvano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of L'Aquila Department of Health Sciences, L'Aquila, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Laparoscopic cholecystectomy is the standard treatment for patients with cholecystitis or gallbladder stones after common bile duct (CBD) clearance. According to the sequential strategy, cholecystectomy should be performed within 2 weeks after CDB clearance with endoscopic retrograde cholangiopancreatography (ERCP). However, in real-life experience, the average waiting time is 60 to 180 days. We aimed to evaluate the clinical rationale for prophylactic stent placement in CBD to prevent recurrent biliary events. This systematic review and meta-analysis was performed following a protocol designed a priori (PROSPERO: CRD42024564804; July 13, 2024). All published studies involving patients who had undergone ERCP for CBDs and who were awaiting cholecystectomy were included. At the end of the revision process, four full texts including 755 patients were included in the meta-analysis. The odds ratio (OR) for symptom recurrence in patients awaiting cholecystectomy was 0.74 (95% confidence interval [CI] 0.30-1.79; I2 67%). The pooled OR for adverse event occurrence was 0.74 (95% CI 0.45-1.24) in the stent group. The post-ERCP pancreatitis and cholangitis risk were 0.76 (95% CI 0.25-2.34) and 0.92 (95% CI 0.31-2.67), respectively. This meta-analysis showed no benefit for stent insertion after bile duct clearance in patients scheduled for delayed cholecystectomy. Further randomized controlled trials with bigger cohorts are needed to assess any benefit for this procedure, which in the meantime, cannot be recommended.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, University of L'Aquila Department of Health Sciences, L'Aquila, Italy.
- S.C. Gastroenterologia, Ente Ospedaliero Ospedali Galliera, Genova, Italy.
- Università Politecnica delle Marche, Ancona, Italy.
- University of Rome Tor Vergata, Roma, Italy.
- Ente Ospedaliero Ospedali Galliera, Genova, Italy.
- Pescara Hospital, Pescara, Italy.
ORCID-Profile: Marco Valvano, Filippo Antonini
Zitieren
APA
Valvano, M., Balducci, D., Vinci, A., Ghezzi, A., Djahandideh, S., Fabiani, S., Stefanelli, G., Buccilli, S., Montale, A., Antonini, F., Maroni, L., & Campanale, C. (2025). Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2586-6007
Vancouver
Valvano M, Balducci D, Vinci A, Ghezzi A, Djahandideh S, Fabiani S, et al. Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2586-6007
BibTeX
@article{Valvano2025,
author = {Valvano, Marco and Balducci, Daniele and Vinci, Antonio and Ghezzi, Andrea and Djahandideh, Shirin and Fabiani, Stefano and Stefanelli, Gianpiero and Buccilli, Silvia and Montale, Amedeo and Antonini, Filippo and Maroni, Luca and Campanale, Chiara},
title = {Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis},
journal = {Endoscopy International Open},
year = {2025},
volume = {13},
number = {CP},
doi = {10.1055/a-2586-6007}
}
EUVIMED